$CCEP

Coca-Cola Europacific buys 180,000 U.S. shares

Coca-Cola Europacific Partners (CCEP) repurchased 180,000 U.S. shares and 73,196 London shares between September 21-25, 2026, as part of its EUR 1 billion share buyback program announced in February 2026. The average price paid for U.S. shares was around USD 101. The repurchased shares will be cancelled.

Original reporting
Published Sep 28, 2026, 11:52 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 12:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CCEP
Bullish
medium confidence
Mentioned
$CCEP
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CCEPBullishLow
01

Why it matters

The immediate effect is a slight reduction in float, which can support the share price, though the scale is limited.

02

Market read

A primary disclosure of a buyback tranche; modest but actionable for short‑term traders monitoring corporate actions.

03

What to watch

Potential future larger buyback phases could amplify impact if the program accelerates.

Relevance 5/10Novelty 6/10Timing: reported today (Sep 28, 2026)

Background

Coca-Cola Europacific Partners announced a share repurchase programme in February 2026 and is now executing the first tranche, buying shares on US and London venues.

Company-level read

Ticker impact

$CCEPBullishMedium confidence
Context

Coca-Cola Europacific Partners disclosed a fresh buyback tranche of 180,000 U.S. shares and 73,196 London shares, cancelling the repurchased stock.

Expected impact

likely modest price lift as the market prices in the share reduction

Evidence & confidence

The tranche size is small relative to market cap, but buybacks are generally viewed positively and can support the price in the short term.

Market effects

Minimal; the buyback does not signal broader sector trends.

Limited to CCEP investors in US and UK markets.

Low; the filing is a company‑specific corporate action.

Counterpoint

Given the modest size, the buyback may be a cosmetic move that does not materially affect valuation.

Key entities

  • Coca-Cola Europacific Partners plc

    Global beverage partner listed on NASDAQ (CCEP) and LSE.

  • Goldman Sachs & Co. LLC

    Seller of the repurchased shares.

Related articles

$CCEPMed

UBS reiterates Neutral rating on Coca-Cola Europacific Partners stock

UBS reiterated a Neutral rating on Coca-Cola Europacific Partners (CCEP) with a $107.00 price target, citing 5.4% Q3 organic sales growth forecast. The stock trades at $100.50, above InvestingPro’s Fair Value estimate. UBS expects growth in Europe and Asia Pacific, with potential for raised full-year revenue guidance. CCEP reported H1 2026 revenue of EUR 10.7 billion, up 6.1%, and EPS growth of 10.6%. Analysts have mixed views on its valuation and outlook.

Low

Coca Cola Europacific Partners (ENXTAM:CCEP) Board Exit Leaves Its Undervalued Case In Focus

Coca-Cola Europacific Partners (CCEP) is under scrutiny after independent non-executive director Nathalie Gaveau resigned, prompting a review of board roles. The company's share price is €88.3, down 6.26% over the past month but up 17.42% year-to-date and 116.77% over five years. Analysts suggest CCEP is 8% undervalued with a fair value of €95.68, citing strong long-term growth prospects in emerging markets and digital investments.

$CCEPHigh

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 403,748 ordinary shares from 7 to 11 September 2026, totaling approximately $43.5 million (USD) and £31.2 million (GBP) on US and London trading venues, respectively. The shares were bought as part of the company's EUR 1 billion share buyback program announced in February 2026. The repurchased shares will be cancelled.

$CCEPHigh

CCEP slips as a fresh Wall Street downgrade adds to valuation concerns

Coca-Cola Europacific Partners (CCEP) fell 3.1% after J.P. Morgan re-initiated coverage with an Underweight rating and a $92 price target, citing valuation concerns and potential slowdown in volume growth. The stock has faced scrutiny due to its premium valuation, despite solid first-half 2026 results. Institutional investors have recently adjusted their positions in CCEP.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.